H.R. 6092 · 116th Congress
Veteran’s Prostate Cancer Treatment and Research Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 116th Congress ended.
R
DunnSponsor3 cosponsors · 1 D, 2 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Mar 5, 2020
- House Passed Sep 22, 2020
This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer.
What it does: CRS summary · Passed House · Sep 22, 2020
Veteran's Prostate Cancer Treatment and Research Act
This bill requires the Department of Veterans Affairs (VA) to implement programs and resources related to the diagnosis and treatment of prostate cancer.
Specifically, the bill requires the VA to establish in its National Surgery Office a national clinical pathway for all stages of prostate cancer that includes specified elements. A clinical pathway is a health care management tool designed around research and evidence-backed practices that provides direction for the clinical care and treatment of a specific episode of a condition or ailment.
The VA must publish the proposed clinical pathway in the Federal Register for public comment. Additionally, the bill requires the VA to publish the established clinical pathway on a public VA website and to update the clinical pathway at least annually.
Under the bill, the VA must submit (1) a plan to establish a comprehensive prostate cancer program, and (2) a plan that provides for continual funding for supporting prostate cancer research through the VA Office of Research and Development. The VA must also establish a program evaluation tool to learn best practices of multidisciplinary disease-based implementation.
Finally, the VA must establish a real-time, actionable, national prostate cancer registry that is accessible to clinicians and researchers.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Veteran's Prostate Cancer Treatment and Research Act
Latest action (Sep 23, 2020): Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Policy area: Armed Forces and National Security · Origin: House · Introduced: Mar 5, 2020
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced Mar 5, 2020
- House Passed Sep 22, 2020
No recorded floor vote found.